Benralizumab
Common brands: Fasenra, Ventolin Hfa, Prednisone, Prednisone Delayed Release, Prednisone Tablets, Usp, 10 Mg
Top reporter: Astrazeneca Pharmaceuticals Lp
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]Corticosteroid [EPC]Interleukin-4 Receptor alpha Antagonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Interleukin-5 Antagonist [EPC]
18,784
Total Reports
13,474
Serious Reports
1,884
Death Reports
30
Reported Reactions
Death Report Ratio: High (10.03%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Benralizumab.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | ASTHMA | 2,880 | |
| 2 | DYSPNOEA | 1,894 | |
| 3 | DEATH | 1,557 | |
| 4 | DRUG INEFFECTIVE | 1,461 | |
| 5 | COUGH | 997 | |
| 6 | PNEUMONIA | 940 | |
| 7 | PRODUCT DOSE OMISSION ISSUE | 909 | |
| 8 | HEADACHE | 902 | |
| 9 | WHEEZING | 715 | |
| 10 | FATIGUE | 614 | |
| 11 | MALAISE | 589 | |
| 12 | INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 569 | |
| 13 | ARTHRALGIA | 534 | |
| 14 | PYREXIA | 528 | |
| 15 | RASH | 500 | |
| 16 | PAIN | 482 | |
| 17 | COVID-19 | 454 | |
| 18 | PRURITUS | 448 | |
| 19 | DIZZINESS | 435 | |
| 20 | CONDITION AGGRAVATED | 427 | |
| 21 | HYPERSENSITIVITY | 420 | |
| 22 | DEVICE LEAKAGE | 404 | |
| 23 | URTICARIA | 401 | |
| 24 | OFF LABEL USE | 390 | |
| 25 | CHEST DISCOMFORT | 385 | |
| 26 | INJECTION SITE PAIN | 379 | |
| 27 | FALL | 377 | |
| 28 | ILLNESS | 346 | |
| 29 | NAUSEA | 332 | |
| 30 | LOWER RESPIRATORY TRACT INFECTION | 295 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.